We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Sprayable Hydrogel Protects Heart from Post-Surgical Adhesions

By HospiMedica International staff writers
Posted on 29 Jun 2021
A new study describes how a novel hydrogel binds to the heart muscle to form a soft, elastic barrier that protects it from adhesions following surgery. More...


Developed at the University of California, San Diego (UCSD; USA), the hydrogel barrier is comprised of aldehyde (ALD), aminooxy (AO), and oxime crosslinked poly(ethylene glycol) (PEG), functionalized with a catechol (CAT) group, that are mixed together to form the final gel (ALD-AO-CAT). The gel has favorable mechanical properties, degradation kinetics, minimal swelling, and superior tissue retention. The material is also cytocompatible, resists cell adhesion, and reduces the severity of adhesions. It can be easily removed from tissue and dissolves after four to six weeks.

The researchers also designed a device to safely and accurately spray the hydrogel inside the surgical field during open heart surgery. The spraying device houses the hydrogel's two main components in two different chambers; each is made of PEG with different reactive groups that crosslink together to form the hydrogel. One of the solutions also includes the catechol-modified PEG to ensure it stays on the heart. The two mix as they exit the device, forming the hydrogel. The researchers described the process as akin to using two cans of spray paint, for example blue and yellow, to create a third color, green. The study was published on June 18, 2021, in Nature Communications.

“We demonstrated here that the ALD–AO–CAT hydrogel possesses mechanical characteristics and degradation kinetics that are well-suited to the conditions within the chest cavity. The material also demonstrated a lower degree of swelling that surpasses the behavior of existing products,” said senior author Professor Karen Christman, PhD, and colleagues. “Our work is an engineering solution driven by a medical problem, and now it's poised to significantly improve cardiac surgery, both for adults and children.”

Depressed fibrinolytic activity resulting from surgical trauma to the epicardium during open-heart procedures can lead to fibrous adhesion formations between the epicardium and other tissues in the chest cavity. For children born with congenital heart defects, who will experience multiple surgeries over their lifetime, and adults receiving valve replacements, mechanical circulatory support, and/or coronary artery bypass grafting, this problem is particularly relevant, as these adhesions impede heart function and severely complicate resternotomy by obstructing visibility and increasing the risk of mortality and morbidity during dissection.

Related Links:
University of California, San Diego


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.